Condition

Chronic Myelogenous Leukemia (CML) (3)

Acute Leukemia (2)

Acute Lymphoblastic Leukemia (ALL) (2)

Acute Myelogenous Leukemia (AML) (2)

Lymphoma (2)

Myelodysplastic Syndrome (MDS) (2)

B Cell Malignancies (1)

Hematological Malignancies (1)

Myelodysplasia (1)

Overall Status

Active, not recruiting (2)

Terminated (1)

Phase

phase 3 (2)

phase 1 (1)

Sponsor

Gamida Cell ltd (1)

Medical College of Wisconsin (1)

Michael Morse, MD (1)

Collaborator

Blood and Marrow Transplant Clinical Trials Network (1)

National Cancer Institute (NCI) (1)

National Heart, Lung, and Blood Institute (NHLBI) (1)

National Marrow Donor Program (1)

Intervention

cord blood unit (1)

cyclophosphamide (1)

methotrexate (1)

mobilized peripheral blood stem cell graft with tacrolimus/methotrexate (1)

mobilized peripheral blood stem cell graft with tacrolimus/mycophenolate mofetil/post-transplant cyclophosphamide (1)

mycophenolate mofetil (1)

nicord® (omidubicel) (1)

tacrolimus (1)

wt1 derived peptides (1)

Study Documents

Intervention Type

drug (2)

biological (1)

other (1)

procedure (1)

Funder Type

Other (2)

Industry (1)

Study Type

Interventional (3)

chronic myelogenous leukemia (cml)

Showing NaN - NaN of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED